Leo Wealth LLC Has $325,000 Holdings in UnitedHealth Group Incorporated $UNH

Leo Wealth LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.4% in the 2nd quarter, Holdings Channel reports. The fund owned 1,041 shares of the healthcare conglomerate’s stock after selling 161 shares during the period. Leo Wealth LLC’s holdings in UnitedHealth Group were worth $325,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the business. McElhenny Sheffield Capital Management LLC raised its stake in UnitedHealth Group by 55.2% during the second quarter. McElhenny Sheffield Capital Management LLC now owns 1,603 shares of the healthcare conglomerate’s stock worth $500,000 after acquiring an additional 570 shares in the last quarter. MSH Capital Advisors LLC raised its stake in UnitedHealth Group by 249.4% during the second quarter. MSH Capital Advisors LLC now owns 3,232 shares of the healthcare conglomerate’s stock worth $1,008,000 after acquiring an additional 2,307 shares in the last quarter. Lokken Investment Group LLC raised its stake in UnitedHealth Group by 17.9% during the second quarter. Lokken Investment Group LLC now owns 2,768 shares of the healthcare conglomerate’s stock worth $864,000 after acquiring an additional 421 shares in the last quarter. Copperwynd Financial LLC raised its stake in UnitedHealth Group by 18.1% during the second quarter. Copperwynd Financial LLC now owns 2,680 shares of the healthcare conglomerate’s stock worth $836,000 after acquiring an additional 410 shares in the last quarter. Finally, Values Added Financial LLC raised its stake in UnitedHealth Group by 24.3% during the second quarter. Values Added Financial LLC now owns 1,105 shares of the healthcare conglomerate’s stock worth $345,000 after acquiring an additional 216 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $354.30 on Friday. The stock has a market capitalization of $320.88 billion, a price-to-earnings ratio of 15.35, a PEG ratio of 2.38 and a beta of 0.47. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The stock’s 50 day moving average price is $318.21 and its two-hundred day moving average price is $350.41. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Analyst Ratings Changes

Several research firms have recently weighed in on UNH. Wells Fargo & Company boosted their price target on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Piper Sandler reduced their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Finally, Robert W. Baird reiterated an “underperform” rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $383.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.